ABCD Move in IBBWith the tech decay started already, the next will be bio-tech. In the long term it pays to be long biotech, but in the short term there is a valuable trade to be made here.
Key stats
About iShares Biotechnology ETF
Expense ratio
0.45%
Home page
Inception date
Feb 5, 2001
IBB tracks an index of US biotechnology companies listed on the major US exchanges. This includes companies engaged in the research and development of therapeutic treatments but are not focused on the commercialization and mass production of pharmaceutical drugs. This also includes companies that are engaged in the production of tools or systems that enable biotechnology processes. IBB includes companies of all capitalizations, and weights using a modified market-cap methodology. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. The index is rebalanced quarterly and fully reconstituted annually in December. Prior to June 21, 2021, the fund was named iShares Nasdaq Biotechnology ETF and tracked the NASDAQ Biotechnology Index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Biotech for continuationBiotech ETF has held up well, and looks primed for bullish continuation. My guess is biotech brands are ramping up. They patent the altered viruses, and then sell you vaccines in a Faustian and Hegelian mix up.
Biotech for continuationBiotech ETF has held up well, and looks primed for bullish continuation. My guess is biotech brands are ramping up. They patent the altered viruses, and then sell you vaccines in a Faustian and Hegelian mix up.
IBB Biotech is due for a runAt some point there will be a boom biotechnology stocks. They haven't done much in the past ten years. I believe IBB will pass 250 within the decade. However, if the market remains stable, without any 20%+ corrections, I think IBB hits 250 to 300 in the next year
IBB - iShares Biotech EFT - SHORT (Wyckoff Redistribution)IBB looks to be in a Wyckoff Redistribution phase, with UTAD emerging currently.
On a larger time frame, looks as though a weekly H&S patter forming with the re-distribution section acting as the right shoulder.
My price target is $57, in line with the 1.618 fib extension.
IBB - long way to go.I will not be bullish in Biotech until we reach the lows (-39% correction) or until we reach new highs.
Should be a lot of mess here, for long period of time without a trend.
IBB d2 accumulation buy/hold setup 40% gains🔸Hello guys, today let's review 2daily chart for IBB . Entering re-accumulation
stage now, expecting range bound trading during autumn time season.
Range defined by range highs set at 135 usd and range lows at 117 usd.
🔸Similar fractal observed in 2018/2019. Faded into range after heavy spike,
re-
IBB Entry, Volume, Target, Stop, ResistanceEntry: with price above 133.81
Volume: with volume greater than 1.67M
Target: 138.50 area
Stop: Depending on your risk tolerance; Based on an entry of 133.82, 132.25 gets you 3/1 Reward to Risk Ratio.
Resistance: 135 area
This swing trade idea is not trade advice and is strictly based on my ideas a
$IBB Setting UpExciting setups this weekend are hard to come by.
$IBB I entered Friday over its inside day & reversed by the close.
Nothing wrong here yet & weekly looks very constructive.
A way to play biotech strength w/o the individual stock risk.
Will be out if it can't hold its 50 MA .
Bullish BiotechClean bottoming pattern formed as well as clean shifting of momentum here
Look for the bull flag breakout of the head and shoulders for 10-15% upside here
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.